These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15232337)

  • 21. Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.
    Chouinard G
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):36S-44S. PubMed ID: 7537286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report.
    Gerding LB; Labbate LA
    Ann Clin Psychiatry; 1999 Jun; 11(2):87-9. PubMed ID: 10440526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
    J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia.
    Angus S; Sugars J; Boltezar R; Koskewich S; Schneider NM
    J Clin Psychopharmacol; 1997 Apr; 17(2):88-91. PubMed ID: 10950469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of tardive dyskinesia with ceruletide: a double-blind, placebo-controlled study.
    Kojima T; Yamauchi T; Miyasaka M; Koshino Y; Nakane Y; Takahashi R; Shimazono Y; Yagi G
    Psychiatry Res; 1992 Aug; 43(2):129-36. PubMed ID: 1357701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients.
    Cassady SL; Thaker GK; Tamminga CA
    Psychopharmacol Bull; 1993; 29(2):235-40. PubMed ID: 8290671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nifedipine in the treatment of tardive dyskinesia.
    Duncan E; Adler L; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Dec; 10(6):414-6. PubMed ID: 1981070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Lerner V; Miodownik C; Kaptsan A; Cohen H; Matar M; Loewenthal U; Kotler M
    Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.
    Cassady SL; Thaker GK; Moran M; Birt A; Tamminga CA
    Biol Psychiatry; 1992 Aug; 32(4):302-11. PubMed ID: 1358231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study.
    Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M
    J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction.
    Thaker GK; Nguyen JA; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):49-59. PubMed ID: 2563231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia.
    El-Sayeh HG; Lyra da Silva JP; Rathbone J; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000458. PubMed ID: 16437424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.